1. Home
  2. Labeler Index
  3. Physicians Total Care, Inc.
  4. 54868-5704
  5. Product Images: Enablex

Product Images Enablex

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. ENABLEX (darifenacin) structural formula - enablex 03
  2. Figure 1 Mean (SD) Steady State Darifenacin Plasma Concentration Time Profiles for ENABLEX® 7.5 and 15 mg in Healthy Volunteers Including Both CYP2D6 EMs and PMs* - enablex 04
  3. Figures 2 a,b,c. Median Change from Baseline at Weeks 2, 6, 12 for Number of Incontinence Episodes per Week (Studies 1, 2 and 3) Figure 2a, Study 1 - enablex 05
  4. Figures 2 a,b,c. Median Change from Baseline at Weeks 2, 6, 12 for Number of Incontinence Episodes per Week (Studies 1, 2 and 3) Figure 2b, Study 2 - enablex 06
  5. Figures 2 a,b,c. Median Change from Baseline at Weeks 2, 6, 12 for Number of Incontinence Episodes per Week (Studies 1, 2 and 3) Figure 2c, Study 3 - enablex 07
  6. PRINCIPAL DISPLAY PANEL - 7.5 mg - package label 01
  7. PRINCIPAL DISPLAY PANEL - 15 mg - package label 02

Product Label Images

The following 7 images provide visual information about the product associated with Enablex NDC 54868-5704 by Physicians Total Care, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

ENABLEX (darifenacin) structural formula - enablex 03

ENABLEX (darifenacin) structural formula - enablex 03

Figure 1 Mean (SD) Steady State Darifenacin Plasma Concentration Time Profiles for ENABLEX® 7.5 and 15 mg in Healthy Volunteers Including Both CYP2D6 EMs and PMs* - enablex 04

Figure 1 Mean (SD) Steady State Darifenacin Plasma Concentration Time Profiles for ENABLEX® 7.5 and 15 mg in Healthy Volunteers Including Both CYP2D6 EMs and PMs* - enablex 04

Figures 2 a,b,c. Median Change from Baseline at Weeks 2, 6, 12 for Number of Incontinence Episodes per Week (Studies 1, 2 and 3) Figure 2a, Study 1 - enablex 05

Figures 2 a,b,c. Median Change from Baseline at Weeks 2, 6, 12 for Number of Incontinence Episodes per Week (Studies 1, 2 and 3) Figure 2a, Study 1 - enablex 05

Figures 2 a,b,c. Median Change from Baseline at Weeks 2, 6, 12 for Number of Incontinence Episodes per Week (Studies 1, 2 and 3) Figure 2b, Study 2 - enablex 06

Figures 2 a,b,c. Median Change from Baseline at Weeks 2, 6, 12 for Number of Incontinence Episodes per Week (Studies 1, 2 and 3) Figure 2b, Study 2 - enablex 06

Figures 2 a,b,c. Median Change from Baseline at Weeks 2, 6, 12 for Number of Incontinence Episodes per Week (Studies 1, 2 and 3) Figure 2c, Study 3 - enablex 07

Figures 2 a,b,c. Median Change from Baseline at Weeks 2, 6, 12 for Number of Incontinence Episodes per Week (Studies 1, 2 and 3) Figure 2c, Study 3 - enablex 07

PRINCIPAL DISPLAY PANEL - 7.5 mg - package label 01

PRINCIPAL DISPLAY PANEL - 7.5 mg - package label 01

This is a label or tag for a product called "ENABLER 7.5K6" that was distributed by "PHYSICIANS TOTAL CARE". The label includes a lot number and expiration date, but not much else is provided. No other information is available from this text.*

PRINCIPAL DISPLAY PANEL - 15 mg - package label 02

PRINCIPAL DISPLAY PANEL - 15 mg - package label 02

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.